Please assess the completion status of the following clinical trial:

Trial Title: Glucocorticoids Promote Osteoclast Survival

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. 18 years old or greater~2. agree to at least one bone biopsy~3. agree to BMD, blood and urine tests~4. receiving at least 10 mg/day of prednisone for at least three months~5. either be a candidate for alendronate or be taking alendronate (70 mg/week for at least three months)~Exclusion Criteria:~1. any metabolic bone disorder such as Paget's disease, renal osteodystrophy, parathyroid disease or osteomalacia~2. obesity enough to make a biopsy difficult~3. concurrent use of any tetracycline~4. hypercalcemia~5. kidney stones in the last two years~6. home O2~7. gastric surgery, stapling or bypass~8. inflammatory bowel disease~9. untreated thyroid disease~10. organ transplants~11. malabsorption~12. anticoagulation~13. current infection~14. serious illness~15. allergy to Demerol, Valium, iodine, tetracycline, tape~16. use of anticonvulsant drugs, heparin, Forteo, calcitonin or high-dose fluoride within the past six months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- glucocorticoids (Type: None): patients receiving glucocorticoid treatment
- glucocorticoids and bisphosphonates (Type: None): patients receiving both glucocorticoids and bisphosphonates

Based on this trial design, predict the completion outcome and termination type (if applicable).